Got a bad back? This is the scientific way to cure it... and it's more effective long term than DRUGS
For talking therapies can help people with lower back pain to live a more active life, scientists found.
And the benefit can be seen for up to three years after treatment.
Psychotherapists use various talking therapies to help people to overcome stress, emotional and relationship problems or troublesome habits.
For some, lower back pain will be a single incident which recovers on its own but most people with the condition will suffer long-term problems with unpredictable flare-ups.
Most treatments for the condition have 'small to moderate' effects that do not last for a long period of time, experts said.
The new study, published in the journal Lancet Rheumatology, focused on a type of psychotherapy called cognitive functional therapy (CFT)—a type of psychotherapy to 'address the causal mechanisms' of chronic lower back pain and help to change the way people think about and respond to pain.
An international team of researchers, led by experts in Australia, wanted to examine whether CFT brought long-term benefits for patients with lower back pain.
More than 1,000 patients from Australia with lower back pain were recruited to the study.
A third were given 'usual care', a third were given CFT and the final third were given CFT plus another technique known as biofeedback, which tries to teach a person to control automatic body functions.
People who received 'usual care' were given what their GP surgery recommended or what they chose.
Some 300 people with an average age of 48 continued the study to the three-year follow-up point, split between each of the three groups.
Researchers found that CFT, and CFT and biofeedback, were both more effective than usual care in reducing activity limitation caused by lower back pain.
And they also were more effective for reducing pain intensity at three years.
There were no significant differences among patients who did and did not use biofeedback techniques, prompting researchers to say the use of biofeedback 'did not add to effectiveness'.
'Treatment sessions of CFT produced sustained effects at three years for people with chronic disabling low back pain,' the researchers wrote.
'These long-term effects are novel and provide the opportunity to markedly reduce the effect of chronic back pain if the intervention can be widely implemented.'
They added: 'CFT is the first treatment for chronic disabling low back pain with good evidence of large, long-term effects on disability.
'It offers a high-value, low-risk intervention with long-term benefits for patients with persistent, disabling low back pain.'
Back pain is the most common form of pain experienced by adults, however, there is usually no immediately identifiable cause.
In many cases, it's a short-term problem, caused by a strain affecting the muscles, tendons or ligaments.
But around nine million people in England live with back pain, according to the charity Arthritis Research UK.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
New weight loss pill more ‘tolerable' than jabs shown to be effective in key trial
A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed kilos in weeks. Its release will offer people with obesity a new and convenient alternative to jabs. Pharmaceutical company Eli Lilly said it expects substantial demand when the new pill is launched. Lilly said it will seek approval by international regulators as it published the results of a large study into orforglipron. The new pill is a GLP-1 agonist, a type of medication which helps lower blood sugar levels, slows the digestion of food and can reduce appetite. The manufacturer also makes Mounjaro, dubbed the King Kong of weight loss jabs. Weight loss jabs have been hailed as transformative by health leaders. But injections come with additional work for over-stretched health services so tablet forms of medication, which are expected to be cheaper and easier to use, may offer a new hope for the millions of people looking to lose weight. The new study data on orforglipron showed that people taking the drug lost an average of 12.3 kilograms while taking the drug for 72 weeks compared with those not taking the drug. Three in five (60 per cent) of people taking the highest dose of orforglipron lost at least 10 per cent of their body weight, while 40 per cent lost at least 15 per cent of their body weight, according to the study, which is to be presented to the European Association for the Study of Diabetes (EASD) Annual Meeting 2025. In addition to weight loss the people in the study also showed other health benefits, including improvements in cholesterol, blood pressure and heart disease risk. Experts highlighted how the tablet did not appear to yield the same benefits as some weight loss jabs, but said they will be more 'tolerable' for many patients. Lilly said the safety profile of the tablet is similar to other GLP-1 drugs, with gastrointestinal issues the most commonly reported side effect. The pill was assessed in a study of 3,127 adults who were obese or overweight, with a weight-related medical problem and without diabetes. 'With orforglipron, we're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments,' said Lilly's Kenneth Custer. 'With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need.' Dr Simon Cork, senior lecturer in physiology at Anglia Ruskin University, said: 'These preliminary results on the effectiveness of orforglipron in promoting clinically significant weight loss are a positive step forward in the development of this class of drugs. 'It should be noted that their effects on weight loss are not as profound as that seen in injectable GLP-1 receptor agonists, such as Wegovy, with a lower percentage weight loss and fewer people achieving 10 per cent weight loss at the highest dose. 'Nevertheless, that this medication is an oral form, rather than injectable, will likely be seen as more tolerable for many patients. 'The manufacturing costs are also anticipated to be significantly lower than injectable drugs, meaning these medications may be more equitable in their availability. 'It should be noted that these are preliminary, non-peer reviewed results and we will need to see the full trial methodology and data before a more comprehensive analysis can be undertaken.' It comes as a separate study highlighted the potential other benefits of using GLP-1s, also known as glucagon-like peptide 1 receptor-agonists. They were initially developed as a treatment for people with type 2 diabetes and are now widely used to treat obesity and help people lose weight. The separate paper, from McGill University and the Lady Davis Institute for Medical Research at the Jewish General Hospital in Canada, examined the benefits of these drugs beyond weight loss by looking at trials which had assessed the drugs in other areas of medicine. Writing in the journal eClinicalMedicine, experts said GLP-1s may also play a role in improving liver disease; sleep apnoea; arthritis of the knee; polycystic ovary syndrome; Parkinson's disease; Alzheimer's disease and substance misuse. But they also highlighted potential safety issues linked to the drugs including potential issues with the pancreas and gall bladder. 'The therapeutic landscape for obesity and related metabolic conditions has evolved substantially with the emergence of GLP-1 RAs,' they wrote. 'These agents now play a central role not only in weight management and diabetes care but are also being investigated in a growing number of conditions, including cardiovascular, renal, hepatic, neurologic, and substance use disorders. 'As their indications expand, so must our understanding of long-term efficacy, safety, and patient-centred treatment strategies.'
Daily Mail
an hour ago
- Daily Mail
Health chiefs sound alarm over deadly thunderstorm asthma which has killed at least 10: 'EVERYONE is at risk'
A leading government health body has issued a warning related to an increasingly common reaction to thunderstorms—life-threatening asthma attacks. And, terrifyingly, the dust and debris whipped up by the atmospheric events also have the potential to trigger an attack in people who do not have asthma. In the newly released guidance about thunderstorm asthma, the UK Health Security Agency (UKHSA) noted a case of the weather-related medical phenomena which occurred in Melbourne, Australia in 2016 which left ten people dead. This, the governing body explains, happened because 'thunderstorm activity is linked to an increase in people reporting asthma symptoms and seeking medical attention for breathing issues. 'It has been observed since the 1980s, with notable events in Birmingham in 1983, and a severe event in Melbourne in 2016, which overwhelmed the city's ambulance system and resulted in 10 deaths.' So what causes thunderstorm asthma? In the run up to a thunderstorm, particularly in the spring and summer months, high winds can whip up pollen spores. As they swirl in the air, they are caught up in lightning strikes, which make the particles even smaller—and more easily breathed in. This, explained a leading doctor, can trigger huge asthma attacks—even in people who are not formally diagnosed with the condition. Jonathan Grigg, Professor of Paediatric Respiratory and Environmental Medicine at Queen Mary University London, said: 'It's not something that only affects individuals who've had a history of wheezing. 'If you start wheezing during a thunderstorm, where there's high pollen, then it could well be thunderstorm asthma. 'People who've got asthma know to take the appropriate precautions, but thunderstorm asthma is something that everyone should know about. 'The idea behind it is that in thunderstorms, you've got rain and lightning, and in the presence of high pollen counts, this transforms and breaks up the pollen, and those little bits get right deep into the lung. 'If you're sensitive to that, it will trigger severe asthma, or make asthma worse—but it can also trigger asthma, even if you've never had it.' Professor Grigg recalled a notable case of youngsters who had had asthma attacks during a thunderstorm which happened just two years ago. He said: 'In London in 2023, there was a similar event with thunderstorms and pollen, and we saw quite a few children with asthma coming in. 'I think about half had no history of actual asthma.' This echoes the UKHSA's guidance, which states: 'Everyone can be at risk of thunderstorm asthma, but young adults under 30 are more likely to be affected. 'There is also some limited evidence that people who have asthma (both diagnosed and undiagnosed), and those who have hay fever, are also more at-risk from the impacts of thunderstorm asthma.' Professor Grigg continued that people travelling abroad also need to know the warning signs, and take necessary precautions. Climate change is making weather patterns across the globe more unpredictable and dramatic—and with an increase in air pollution, which has also been linked to respiratory conditions—thunderstorm asthma is becoming a growing risk. 'As you move further south across the European continent, you've got areas around mountains which have high pollen, and thunderstorms which happen all the time, so we, fortunately don't, in the UK, get as many cases of thunderstorm asthma as other areas.' He also shared some As well as 'knowing the pollen count', Professor Grigg explained that there are steps you can take to reduce the risk of suffering a thunderstorm asthma attack. 'If the pollen count is very high and there's a thunderstorm, especially ones with gusty winds, then you shouldn't be outside. 'Stay indoors and shut the windows. 'You definitely shouldn't be wandering around, especially in the beginning of a storm when you get very windy conditions. 'Make sure that you're taking your inhaler, especially the the steroid preventer inhaler, and carry your reliever with you. 'Ensure you're fully medicated as you're as instructed by your physician.' The same advice applies for if you're caught up in a thunderstorm in an urban area, too. 'If you have high pollen, high pollution and thunderstorm, you could get a perfect conditions for thunderstorm asthma,' he warned. Asthma affects around 7.2million people in the UK, and asthma attacks kill, on average, three people in Britain every day. It affects the airways, or breathing tubes, that carry air in and out of the lungs, causing them to become inflamed. This makes the airways narrower so less air gets into and out of the lungs. Symptoms include wheezing, breathlessness, a cough or a tight chest — and are often triggered by factors in the environment like pollution, stress or a cold. There is no cure, but inhalers work to control the disease by reducing the number of blood cells that contribute to the lung inflammation. Emma Rubach, Head of Health Advice at Asthma + Lung UK, said: 'People with asthma who have hay fever can experience much more severe symptoms during thunderstorms. 'This is because thunder breaks pollen into smaller particles, which can then be inhaled deep into the lungs, causing wheezing, coughing, a tight chest and shortness of breath. 'If there is also higher pollution in the atmosphere – which tends to be the case when the weather is warm – this is an added threat.'
The Guardian
3 hours ago
- The Guardian
Afternoon Update: what the Erin Patterson jury wasn't told; Israel announces plan to take over Gaza City; and anti-boogie bummers
Good afternoon. New material and claims that were not allowed to be heard by the jury in Erin Patterson's triple murder trial have now been made public, after an interim suppression order was lifted. One argument heard in court, but ruled inadmissible by the trial judge, involved police suspicions that Patterson might have previously used rat poison in an alleged attempt to kill her estranged husband, Simon. The pre-trial hearings also heard that Simon had told his father, Don, and other family members of his suspicions before the fatal beef wellington lunch in July 2023, but that 'he thought he was the only person she was targeting, and that [his relatives] would be safe'. Meanwhile, the Victorian supreme court has released redacted footage of Patterson's interview with police, conducted a week after the fatal lunch, in which she told police she did not own a dehydrator nor ever foraged for mushrooms – evidence she later admitted in court were lies. This interview was played to the jury during the trial but has not been released publicly until now. Netanyahu announces plan to take over Gaza City, marking another escalation in devastating war Minns says Folbigg 'free' to sue his government if $2m not enough for 20 years in jail for wrongful convictions Six-year-old girl dies of influenza after twice being discharged from Sydney hospital Trump claims to have reached 'historic' peace deal between Armenia and Azerbaijan South Korea set to decide whether to let Google Maps finally work properly Elite netballers reveal distress after singer who pleaded guilty to domestic violence performs at grand final One doctor's hopes to rebuild Gaza's health system Abdalkarim Alharazin has seen more suffering and death than most in his time as a junior doctor on Gaza's frontlines. Amid relentless Israeli bombardment, displacement and starvation, the Palestinian paediatrician applied for and has been accepted into a master of public health at the University of Sydney. With significant hurdles ahead, logistically and financially, Alharazin joins Nour Haydar to talk about what he's witnessed and his plans to rebuild Gaza's health infrastructure. Listen to the episode here Sorry your browser does not support audio - but you can download here and listen $ 'How can you represent your community from behind bars?' – Chris Minns The New South Wales premier said Gareth Ward's resignation from the state parliament on Friday 'should have come earlier' after the convicted rapist resigned as MP for Kiama moments before parliament was due to expel him. Ward, who is on remand in Cessnock prison, on Thursday lost his bid for an injunction to prevent his expulsion while he appealed his conviction. His resignation now automatically vacates his south coast seat, meaning there will be a byelection. Andrew Bragg on AI, housing and what the Coalition got wrong – Australian Politics podcast Sign up to Afternoon Update Our Australian afternoon update breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion Two weeks out from Labor's economic roundtable, the Coalition's shadow minister for productivity, housing and homelessness, Andrew Bragg, joins us to talk about the biggest challenges facing the economy. Speaking to chief political correspondent Tom McIlroy, Bragg cautions against over-regulating artificial intelligence, reflects on the Coalition's missteps with migrant communities, and reveals how he still carves out time for long runs and audiobooks amid the chaos of federal politics. Listen to the episode here Sorry your browser does not support audio - but you can download here and listen $ Any reasonable gig-goer knows that dancing is part of the show. So why are some people such anti-boogie bummers? Live music always reminds Zoya Patel how special art is, and how lucky we are when we experience it together, she writes. If you can't be in public without trying to control other people's every movement, maybe you should just stay at home? Today's starter word is: TYPE. You have five goes to get the longest word including the starter word. Play Wordiply. Enjoying the Afternoon Update? Then you'll love our Morning Mail newsletter. Sign up here to start the day with a curated breakdown of the key stories you need to know, and complete your daily news roundup. And follow the latest in US politics by signing up for This Week in Trumpland.
